This article was accepted into the corpus but its outbound wikilinks were never NER-processed — typical at the deepest BFS hop or when the run's entity cap was reached. No expansion funnel to show.
| Research Governance Framework for Health and Social Care | |
|---|---|
| Name | Research Governance Framework for Health and Social Care |
| Abbreviation | RGfHSC |
| Jurisdiction | United Kingdom |
| Established | 2001 |
| Replaced | National Health Service Research Governance Framework |
Research Governance Framework for Health and Social Care The Research Governance Framework for Health and Social Care is a policy and operational schema that defines standards for conducting health and social care research across the United Kingdom. It integrates statutory duties, professional standards, and institutional responsibilities to protect participants, ensure scientific integrity, and align research with public funding priorities. The framework informs institutions ranging from NHS trusts to universities and regulators such as the Medicines and Healthcare products Regulatory Agency and the Health Research Authority.
The framework emerged amid reforms involving the National Health Service (England), Department of Health and Social Care (United Kingdom), and advisory bodies including Medical Research Council, National Institute for Health and Care Excellence, Care Quality Commission, Health and Social Care Information Centre to harmonize standards across clinical trial governance, social care studies, and translational research. Influenced by international instruments such as the Declaration of Helsinki, the framework sits alongside instruments like the European Union Clinical Trials Directive and guidance from World Health Organization bodies. It responds to prior inquiries and reports by entities including Acheson Committee, Cochrane Collaboration, and independent inquiries into research conduct.
The framework covers research involving participants in settings overseen by National Health Service (England), local authorities, independent providers such as Care Quality Commission–regulated services, and academic institutions including University of Oxford, University of Cambridge, University College London, and other higher education institutions. Objectives include protecting participants under statutes like the Data Protection Act 2018 and complying with the Human Rights Act 1998, promoting research quality as expected by funders such as UK Research and Innovation, Wellcome Trust, and aligning with regulatory clearance from Medicines and Healthcare products Regulatory Agency and ethical approval by committees like the NHS Research Ethics Committee.
Principles center on participant safety, scientific validity, transparency, and accountability as reflected by precedents from Nuremberg Code, Declaration of Helsinki, and advisory outputs by Culture, Media and Sport Committee inquiries into research ethics. Ethical considerations require informed consent processes consistent with standards from General Medical Council and oversight by research ethics committees such as those coordinated by the Health Research Authority. Conflicts of interest must be managed per guidance from Committee on Publication Ethics and funder policies from Wellcome Trust and Medical Research Council.
Legal underpinnings include statutes and directives like the Health and Social Care Act 2012, Data Protection Act 2018, Human Tissue Act 2004, and regulations from the European Medicines Agency. Compliance obligations intersect with licensing and inspection roles of the Medicines and Healthcare products Regulatory Agency, information governance overseen by the Information Commissioner's Office, and clinical trial authorization channels linked to MHRA Clinical Trials Authorization. Case law precedents from courts such as the Supreme Court of the United Kingdom inform interpretation of duty of care and consent.
Implementation involves multi-layered governance: sponsor organizations such as universities (e.g., University of Manchester, King's College London), healthcare providers including Guy's and St Thomas' NHS Foundation Trust and Royal Free London NHS Foundation Trust, research governance offices, and national bodies like the Health Research Authority and National Institute for Health Research. Roles delineate responsibilities for principal investigators, sponsors, host organisations, and research governance leads, with professional input from bodies such as the Royal College of Physicians, Royal College of Nursing, and British Psychological Society.
Approval pathways require ethical approval from NHS Research Ethics Committee networks, regulatory approval from Medicines and Healthcare products Regulatory Agency, and local governance sign-off by trust research and development departments. Oversight mechanisms include trial registration on registries analogous to ISRCTN Registry and reporting obligations to funders such as National Institute for Health Research and sponsors like Wellcome Trust. Serious breaches invoke reporting to regulatory bodies including the Care Quality Commission and statutory notifications under the Health and Social Care Act 2008.
Data governance adheres to Data Protection Act 2018 and guidance from the Information Commissioner's Office, with technical standards influenced by national programs like NHS Digital and interoperability initiatives such as NHS Spine. Pseudonymisation, anonymisation, secure data transfer, and data sharing agreements must meet expectations set by funders including UK Research and Innovation and the Wellcome Trust and align with legal tests under the Human Rights Act 1998. Data access committees, institutional data controllers, and processors coordinate with health informatics units in organisations like University College London Hospitals NHS Foundation Trust.
Monitoring frameworks include risk-proportionate monitoring plans, audit by host organisations and external sponsors, and inspection by regulators such as the Medicines and Healthcare products Regulatory Agency and Care Quality Commission. Quality assurance spans trial conduct, data integrity, and adverse event reporting consistent with guidelines from the International Conference on Harmonisation and standards promoted by bodies like the National Institute for Health and Care Excellence. Continuous improvement is supported through learning networks involving institutions such as Health Education England and research consortia including UK Biobank.
Category:Health research governance